Stan Smith, Director at MAIA Biotechnology, Inc. (MAIA), bought 133,300 shares at $2.25 ($300K) on 2023-04-27, disclosed to the SEC on 2023-04-28.
Open-market purchase of $300k MAIA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| MAIA | BUY | 2025-12-23 | $140K | — | Filing → |
| MAIA | BUY | 2025-12-09 | $11K | — | Filing → |
| MAIA | BUY | 2025-12-01 | $16K | — | Filing → |